Rankings
▼
Calendar
PEPG Q2 2024 Earnings — PepGen Inc. Revenue & Financial Results | Market Cap Arena
PEPG
PepGen Inc.
$435M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$30M
Net Income
-$28M
EPS (Diluted)
$-0.87
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$16M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$194M
Total Liabilities
$38M
Stockholders' Equity
$155M
Cash & Equivalents
$66M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$30M
-$21M
-43.9%
Net Income
-$28M
-$20M
-45.1%
← FY 2024
All Quarters
Q3 2024 →